| Scientific Advisory Board Walter McConathy, PhD | University of Oklahoma, retired Professor of Internal Medicine, Texas Tech University Health Science Center, Odessa TX. Academic research career focusing on plasma lipoproteins related to atherosclerosis /diabetes, apolipoprotein structure and function. Jointly developed rHDL as vehicle for targeted delivery of anticancer agents via SR-B1 receptor. |
| Scientific Advisory Board Andras Lacko, PhD | University of Washington, Seattle. Professor of Molecular Biology at the University of North Texas Health Science Center. Academic career focused on plasma lipoproteins and the plasma enzyme LCAT. Jointly developed rHDL as vehicle for targeted delivery of anticancer agents via SR-B1 receptor |
